Colgate-Palmolive (NYSE:CL) Shares Sold by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 28.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,409 shares of the company’s stock after selling 24,956 shares during the period. Gulf International Bank UK Ltd’s holdings in Colgate-Palmolive were worth $6,478,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at about $25,000. Continuum Advisory LLC grew its stake in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Gradient Investments LLC grew its holdings in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. Finally, Financial Connections Group Inc. purchased a new position in Colgate-Palmolive in the second quarter valued at about $68,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 29th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Finally, Evercore ISI lifted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $105.11.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $93.61 on Tuesday. The stock has a market capitalization of $76.48 billion, a PE ratio of 26.82, a P/E/G ratio of 3.33 and a beta of 0.42. The business has a fifty day moving average price of $102.03 and a two-hundred day moving average price of $98.40. Colgate-Palmolive has a fifty-two week low of $74.67 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.